"We are convinced that producing this Technology Roadmap will fundamentally change the dynamics of the industry"
London, UK (PRWEB) March 09, 2016
With over 100 people now actively involved in the roadmapping process, led by a strong VP level steering committee and six teams working on the key technology challenges, a considerable capability has already been built to drive through the necessary industry changes.
Bringing together industry stakeholders in a professionally facilitated collaboration is enabling global industry progress to be accelerated, ultimately bringing through the innovations needed to get better medicines through to patients globally at a far faster rate.
According to Steve Jones of BioPhorum “We are convinced that producing this Technology Roadmap will fundamentally change the dynamics of the industry and establish a long lasting, cooperative relationship between biopharmaceutical manufacturers, supply partners, academics, regulators and regional hubs”.
The complexity of the current industry structure has traditionally held back innovation with many end users trying to develop new technologies in isolation and suppliers having to guess end user requirements. The Technology Roadmap is being developed in response to this common industry problem and is being professionally facilitated by The BioPhorum Operations Group, a highly effective industry collaboration that has been running for the past 9 years with other 1800 active participants globally. The Technology Roadmapping process is a natural extension of their highly effective forums on drug substance, fill-finish, development, IT and supply partners.
When complete, The Technology Roadmap will be available free to everyone and updated and published on a regular basis.
For more information go to:- http://www.biophorum.com/article/160/technology-roadmapping
For interviews please contact: Steve Jones, Director, BioPhorum, Tel: +44 7710 878181 steve(at)biophorum(dot)com http://www.biophorum.com
About The BioPhorum Operations Group
Since its inception in 2004, the BioPhorum has become the open and trusted environment where senior leaders of the biopharma industry come together to openly share and discuss the emerging trends and challenges facing their industry. The strong cross-company relationships built through the Biophorum have provided the solid foundation from which highly effectives collaborations have grown, each focusing on the key operational challenges, improving competitiveness and reducing patient risk. As well as The Technology Roadmap, BioPhorum runs 5 other forums – Drug Substance, The Development Group, Fill Finish, IT and Supply Partner.